Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Randomized controlled trial of pharmacological replacement of melatonin for sleep disruption in individuals with tetraplegia.

Zeitzer JM, Ku B, Ota D, Kiratli BJ.

J Spinal Cord Med. 2014 Jan;37(1):46-53. doi: 10.1179/2045772313Y.0000000099. Epub 2013 Oct 24.

2.

Sleep disruption in tetraplegia: a randomised, double-blind, placebo-controlled crossover trial of 3 mg melatonin.

Spong J, Kennedy GA, Tseng J, Brown DJ, Armstrong S, Berlowitz DJ.

Spinal Cord. 2014 Aug;52(8):629-34. doi: 10.1038/sc.2014.84. Epub 2014 Jun 3.

PMID:
24891007
3.

Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.

Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, Ruotsalainen JH.

Cochrane Database Syst Rev. 2014 Aug 12;8:CD009776. doi: 10.1002/14651858.CD009776.pub2. Review.

PMID:
25113164
4.

A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study.

Sleep. 2003 Nov 1;26(7):893-901.

5.

Pilot Study on the Effect of Ramelteon on Sleep Disturbance After Traumatic Brain Injury: Preliminary Evidence From a Clinical Trial.

Lequerica A, Jasey N, Portelli Tremont JN, Chiaravalloti ND.

Arch Phys Med Rehabil. 2015 Oct;96(10):1802-9. doi: 10.1016/j.apmr.2015.05.011. Epub 2015 May 28.

PMID:
26026580
6.

The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).

Appleton RE, Jones AP, Gamble C, Williamson PR, Wiggs L, Montgomery P, Sutcliffe A, Barker C, Gringras P.

Health Technol Assess. 2012;16(40):i-239. doi: 10.3310/hta16400.

7.

A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome.

Kayumov L, Brown G, Jindal R, Buttoo K, Shapiro CM.

Psychosom Med. 2001 Jan-Feb;63(1):40-8.

PMID:
11211063
8.

Pharmacotherapies for sleep disturbances in Alzheimer's disease.

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2014 Mar 21;3:CD009178. doi: 10.1002/14651858.CD009178.pub2. Review.

PMID:
24659320
9.

Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.

Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, Malhotra A, Shea SA.

Sleep. 2012 Oct 1;35(10):1395-402.

10.

Subjective sleep disturbances and quality of life in chronic tetraplegia.

Spong J, Graco M, Brown DJ, Schembri R, Berlowitz DJ.

Spinal Cord. 2015 Aug;53(8):636-40. doi: 10.1038/sc.2015.68. Epub 2015 Apr 21.

PMID:
25896348
11.

Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment.

McArthur AJ, Budden SS.

Dev Med Child Neurol. 1998 Mar;40(3):186-92.

12.

A randomized controlled trial with bright light and melatonin for the treatment of delayed sleep phase disorder: effects on subjective and objective sleepiness and cognitive function.

Wilhelmsen-Langeland A, Saxvig IW, Pallesen S, Nordhus IH, Vedaa Ø, Lundervold AJ, Bjorvatn B.

J Biol Rhythms. 2013 Oct;28(5):306-21. doi: 10.1177/0748730413500126.

PMID:
24132057
13.

The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.

Zemlan FP, Mulchahey JJ, Scharf MB, Mayleben DW, Rosenberg R, Lankford A.

J Clin Psychiatry. 2005 Mar;66(3):384-90.

PMID:
15766306
14.

Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.

Eckerberg B, Lowden A, Nagai R, Akerstedt T.

Chronobiol Int. 2012 Nov;29(9):1239-48. doi: 10.3109/07420528.2012.719962. Epub 2012 Sep 24.

PMID:
23005039
15.

A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.

Roth T, Seiden D, Wang-Weigand S, Zhang J.

Curr Med Res Opin. 2007 May;23(5):1005-14.

PMID:
17519067
16.

Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.

Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.

Curr Med Res Opin. 2007 Oct;23(10):2597-605.

PMID:
17875243
17.

Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.

Chang YS, Lin MH, Lee JH, Lee PL, Dai YS, Chu KH, Sun C, Lin YT, Wang LC, Yu HH, Yang YH, Chen CA, Wan KS, Chiang BL.

JAMA Pediatr. 2016 Jan;170(1):35-42. doi: 10.1001/jamapediatrics.2015.3092.

PMID:
26569624
18.

Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.

Gooneratne NS, Gehrman P, Gurubhagavatula I, Al-Shehabi E, Marie E, Schwab R.

J Clin Sleep Med. 2010 Dec 15;6(6):572-80.

19.

Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Medeiros CA, Carvalhedo de Bruin PF, Lopes LA, Magalhães MC, de Lourdes Seabra M, de Bruin VM.

J Neurol. 2007 Apr;254(4):459-64. Epub 2007 Apr 3.

PMID:
17404779
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk